天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Anti-CDK5(N-term) Monoclonal Antibody,Anti-CDK5(N-term) Monoclonal Antibody
  • Anti-CDK5(N-term) Monoclonal Antibody,Anti-CDK5(N-term) Monoclonal Antibody

Anti-CDK5(N-term) Monoclonal Antibody

價格 1600.00 960.00
包裝 100ul 50ul
最小起訂量 50ul
發(fā)貨地 北京
更新日期 2024-12-27
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:Anti-CDK5(N-term) Monoclonal Antibody英文名稱:Anti-CDK5(N-term) Monoclonal Antibody
Gene ID: 1020Public Immunogen Range: Purified recombinant human CDK5(N-terminus) protein fragments expressed in E.coli.
Swiss Prot: Q00535保存: Store at -20°C. Avoid freeze / thaw cycles.
別名: LIS7;PSSALRE產(chǎn)品編號: K001394M
儲存液: Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.純化方法: Affinity purification
蛋白分子量: 33kDa克隆號: 2E8-F9-B7-C11
克隆類型: Monoclonal Antibody免疫原: Purified recombinant human CDK5(N-terminus) protein fragments expressed in E.coli.
品牌: solarbio宿主: Mouse
稀釋比例: WB 1:500. IHC 1:150.性狀: 液體
亞型: IgG1應(yīng)用: WB ICC
英文名稱: Anti-CDK5(N-term) Monoclonal Antibody
2024-12-27 Anti-CDK5(N-term) Monoclonal Antibody Anti-CDK5(N-term) Monoclonal Antibody 100ul/1600.00RMB;50ul/960.00RMB 1600.00

背景資料

Cdks (cyclin-dependent kinases) are heteromeric serine/threonine kinases that control progression through the cell cycle in concert with their regulatory subunits, the cyclins. Although there are 12 different cdk genes, only 5 have been shown to directly drive the cell cycle (Cdk1, -2, -3, -4, and -6). Following extracellular mitogenic stimuli, cyclin D gene expression is upregulated. Cdk4 forms a complex with cyclin D and phosphorylates Rb protein, leading to liberation of the transcription factor E2F. E2F induces transcription of genes including cyclins A and E, DNA polymerase and thymidine kinase. Cdk4-cyclin E complexes form and initiate G1/S transition. Subsequently, Cdk1-cyclin B complexes form and induce G2/M phase transition. Cdk1-cyclin B activation induces the breakdown of the nuclear envelope and the initiation of mitosis. Cdks are constitutively expressed and are regulated by several kinases and phosphastases, including Wee1, CDK-activating kinase and Cdc25 phosphatase. In addition, cyclin expression is induced by molecular signals at specific points of the cell cycle, leading to activation of Cdks. Tight control of Cdks is essential as misregulation can induce unscheduled proliferation, and genomic and chromosomal instability. Cdk4 has been shown to be mutated in some types of cancer, whilst a chromosomal rearrangement can lead to Cdk6 overexpression in lymphoma, leukemia and melanoma. Cdks are currently under investigation as potential targets for antineoplastic therapy, but as Cdks are essential for driving each cell cycle phase, therapeutic strategies that block Cdk activity are unlikely to selectively target tumor cells.

Subcellular Locations

Cell junction Cell membrane Cell projection Cytoplasm Nucleus Perikaryon Peripheral membrane protein growth cone lamellipodium postsynaptic cell membrane postsynaptic density synapse
關(guān)鍵字: Anti-CDK5(N-term) Monoclonal Antibody;抗體

公司簡介

北京索萊寶科技有限公司是一家集研發(fā)、生產(chǎn)、銷售、服務(wù)于一體的高科技生物企業(yè)。技術(shù)推廣;技術(shù)轉(zhuǎn)讓;技術(shù)咨詢;技術(shù)服務(wù);生物試劑技術(shù)開發(fā);銷售生物試劑盒、實(shí)驗(yàn)室專用化學(xué)試劑、實(shí)驗(yàn)室專用設(shè)備、辦公用品、化工產(chǎn)品(不含危險化學(xué)品)、計算機(jī)軟件及輔助設(shè)備;貨物進(jìn)出口、技術(shù)進(jìn)出口、代理進(jìn)出口;委托加工生產(chǎn)生物制品、生化制品、化工產(chǎn)品(不含危險化學(xué)品);生產(chǎn)生物試劑盒;批發(fā)第一類醫(yī)療器械、第二類醫(yī)療器械;批發(fā)第三類醫(yī)療器械。
成立日期 2004-09-22 (21年) 注冊資本 1000萬元
員工人數(shù) 50-100人 年營業(yè)額 ¥ 500萬-1000萬
主營行業(yè) 分析化學(xué),生物化工,化學(xué)試劑,醫(yī)藥原料,儀器耗材 經(jīng)營模式 貿(mào)易,工廠,試劑
  • 北京索萊寶科技有限公司
VIP 9年
  • 公司成立:21年
  • 注冊資本:1000萬元
  • 企業(yè)類型:有限責(zé)任公司
  • 主營產(chǎn)品:tris,甘氨酸,瓊脂粉,潮霉素B,SDS,BSA
  • 公司地址:聯(lián)東U谷景盛南四街85A三層
詢盤

Anti-CDK5(N-term) Monoclonal Antibody相關(guān)廠家報價

產(chǎn)品名稱 價格   公司名稱 報價日期
¥1098
VIP3年
上海滬震實(shí)業(yè)有限公司
2024-12-27
詢價
碧云天生物技術(shù)有限公司
2024-12-25
¥920
愛必信(上海)生物科技有限公司
2023-10-16
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價格指該商品的參考價格,并非原價,該價格可能隨著市場變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價格,請咨詢商家,以實(shí)際成交價格為準(zhǔn)。請意識到互聯(lián)網(wǎng)交易中的風(fēng)險是客觀存在的